Publication | Open Access

Semaglutide in patients with overweight or obesity and chronic kidney disease without diabetes: a randomized double-blind placebo-controlled clinical trial

ObesityMetabolic SyndromeDiabetes ManagementRenal FunctionMedicineDiabetesChronic Kidney DiseaseClinical TrialsDiabetic Kidney DiseasePharmacotherapyPharmacologyHealth Sciences